HEPSANET at the International Liver Congress 2022

Written By Alexander Stockdale

Members of HEPSANET travelled to London for the International Liver Congress in April. We caught up on the latest research news in the world of viral hepatitis.

Our first HEPSANET scientific output was presented in an oral presentation session and the abstract has been published in the Journal of Hepatology. More details on the project is found on the project page- biomarkers. Click to see the full abstract.

Several members of HEPSANET also presented exciting data from their sites.

The Ethiopia site presented data from five year follow up from their cohort (click to see full PDF).

Colleagues from the Gambia presented on the coverage of hepatitis B birth dose vaccination:

Colleagues from the Gambia also presented data on use of hepatitis B core related antigen used to identify patients eligible for antiviral therapy:

Alexander Stockdale
Previous

HEPSANET paper on low cost biomarkers for fibrosis is published in Nature Communications